Roivant Sciences Ltd. - Common Shares (NQ:ROIV)All News about Roivant Sciences Ltd. - Common Shares![]()
Assessing Roivant Sciences: Insights From 5 Financial Analysts
January 02, 2024
Via Benzinga
![]() ![]()
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
December 20, 2023
From Roivant Sciences
Via GlobeNewswire
![]() ![]()
Analyst Ratings for Roivant Sciences
December 12, 2023
Via Benzinga
![]()
8 Analysts Have This to Say About Roivant Sciences
November 14, 2023
Via Benzinga
![]()
Roivant Sciences Earnings Preview
November 10, 2023
Via Benzinga
![]()
What 8 Analyst Ratings Have To Say About Roivant Sciences
October 17, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() From Roivant Sciences
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() From Covant Therapeutics
Via GlobeNewswire
![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms Of Service. |
|